Evidence map›Paper›PMID 27594430›Full record

ArticleAmerican journal of clinical pathology2016

Accurate Real-Time Diagnosis of Lymphoproliferative Disorders in Malawi Through Clinicopathologic Teleconferences:  A Model for Pathology Services in Sub-Saharan Africa.

Nathan D Montgomery, N George Liomba, Coxcilly Kampani, Robert Krysiak, Christopher C Stanley, Tamiwe Tomoka, Steve Kamiza, Bal M Dhungel, Satish Gopal, Yuri Fedoriw

Abstract read
In one paragraph

Article in American journal of clinical pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nathan D MontgomeryFrom the Department of Pathology and Laboratory Medicine, Division of Hematopathology.
N George LiombaUNC Project-Malawi, Lilongwe, Malawi.
Coxcilly KampaniUNC Project-Malawi, Lilongwe, Malawi.
Robert KrysiakUNC Project-Malawi, Lilongwe, Malawi.
Christopher C StanleyUNC Project-Malawi, Lilongwe, Malawi.
Tamiwe TomokaUniversity of Malawi College of Medicine, Blantyre, Malawi.
Steve KamizaUniversity of Malawi College of Medicine, Blantyre, Malawi.
Bal M DhungelUNC Project-Malawi, Lilongwe, Malawi.
Satish GopalProgram in Global Oncology, Lineberger Comprehensive Cancer Center, and UNC Project-Malawi, Lilongwe, Malawi.
Yuri FedoriwFrom the Department of Pathology and Laboratory Medicine, Division of Hematopathology Program in Global Oncology, Lineberger Comprehensive Cancer Center, and Yuri.Fedoriw@unchealth.unc.edu.

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
University of Southern CaliforniaU01CA121947 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MITSUYASU, RONALD T. · 2006 to 2014
$54.7M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
Project 3U54CA190152 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAMANIA, BLOSSOM A, GOPAL, SATISH · 2014 to 2019
$4.2M
Developing a clinical cohort of histopathologically characterized lymphomaK01TW009488 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GOPAL, SATISH · 2012 to 2016
$701k
Molecular profiling of HIV-associated lymphoma in the US and MalawiR21CA180815 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GOPAL, SATISH · 2013 to 2014
$341k
FIC NIH HHS K01 TW009488NCI NIH HHS P30 CA016086NCI NIH HHS R21 CA180815NCI NIH HHS U01 CA121947NCI NIH HHS U54 CA190152NIAID NIH HHS P30 AI050410NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

objectivesThe incidence of lymphoproliferative disorders (LPDs) is increasing in sub-Saharan Africa (SSA) due to population growth, aging, and human immunodeficiency virus (HIV). Despite significant burden, resources for diagnosis and treatment of LPDs are limited, with little infrastructure to deliver modern pathology services. Diagnostic and therapeutic decisions are therefore frequently made without tissue confirmation, leading to high rates of misdiagnosis and inappropriate treatment.

methodsWe have established a laboratory in Malawi to support clinical and research efforts at a national teaching hospital. Consensus real-time diagnoses are rendered by local pathologists after weekly clinicopathologic teleconferences involving clinicians and pathologists from the United States and Malawi. Additional ancillary studies are then performed in the United States prior to final diagnosis.

resultsWe report our first 2 years' experience and demonstrate high concordance between real-time diagnoses in Malawi and final diagnoses in the United States (5% major discordance rate for formalin-fixed, paraffin-embedded samples). In addition, we describe characteristics of pathologically confirmed LPDs in Malawi, highlighting differences by HIV status.

conclusionsOur multidisciplinary approach can be a model for strong pathology services that provide direct, real-time support to clinical care and research in SSA.

Indexed as

TelepathologyAdolescentAdultChildChild, PreschoolFemaleHumansLymphoproliferative DisordersMalawiMaleMiddle AgedLymphoproliferative disordersResource-limited settingSub-Saharan AfricaTelepathology

Identifiers

PMID27594430
PMCPMC5040876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.